TrialThe American journal of cardiology2017

Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.

Eva S Laube et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.